Hitachi to Deliver Response Genetics’ Clinical Sample Testing Tech in Asia-Pacific | GenomeWeb
NEW YORK (GenomeWeb News) - Response Genetics today said it has struck an agreement with Hitachi Chemical that will allow Hitachi to use its genetic diagnostic testing methods and services for formalin-fixed paraffin-embedded tissue samples in Southeast Asia, Australia, and New Zealand. 
 
Hitachi will also give Response Genetics access to “potential new testing services customers” in Asia for its FFPE clinical sample testing technology, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.